Stock·NYSE·Consumer Defensive
Procter & Gamble Co (PG)
- Market cap
- $370.66B
- P/E
- 24.08
- Dividend yield
- 2.70%
- Street target
- $163.00median of 25 analysts
- 52-week range
- $137.62 $167.25
PG stock forecast today
Where PG stands today, and what CleaRank Financial AI makes of it.
PG at a glance
Procter & Gamble Co (PG): Buy, 74/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($148.67 and $148.61).
- Earnings PG beat estimates in 6 of the 6 reports in our data, yet fell the next day after 4 of those beats.
- Insiders Insiders sold $89.7M and made no open-market purchases over the last 18 months.
- Valuation P/E of 24.1 against 24.2 for the Consumer Defensive sector: broadly in line with peers (0%).
Figures as of October 26, 2026.
CleaRank Financial AI
PG earns a Buy rating from CleaRank, backed by a model score of 74/100.
Its trend contributes the most to that score: the price is 7.61% above its 200-day average and 7.56% above its 50-day, and the 50-day average is 0.05% above the 200-day. Valuation pulls hardest in the other direction, with the P/S of 4.24 92.7% above the sector median. The 50-day average is $148.67 and the 200-day is $148.61, and over the past year the price has climbed 4.87%.
Only on CleaRank
Figures we compute ourselves from PG's own price, earnings and insider-filing history. Tap one to see it in context.
PG stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $159.92 is 7.6% above the 50-day simple moving average of $148.67.Price above its 200-day average ›
The price is 7.6% above the 200-day simple moving average of $148.61.50-day average above the 200-day ›
The 50-day average ($148.67) is 0.0% above the 200-day average ($148.61), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 75% of its 52-week range, between $137.62 and $167.25.
PG share price
Pick a period: each tab shows how far PG has moved over it, to the last close.
Today's trading
Where PG sits inside today's range and its 52-week range.
PG fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 24.08 is 0.5% below the Consumer Defensive median of 24.2.P/S below the sector median ›
The price-to-sales ratio of 4.24 is 92.9% above the sector median of 2.2.Profitable over the last 12 months ›
Net income over the last 12 months was $15.7B on revenue of $87.9B, a net margin of 17.9%.Beat estimates in most recent reports ›
PG beat the EPS estimate in 6 of the 6 reports in our data.Pays a dividend ›
The trailing dividend yield is 2.70%, or $4.32 a share a year.
Key statistics
The headline figures for PG.
As of October 26, 2026, PG trades at $159.92, with a market value of $370.66B, a P/E ratio of 24.08 and a dividend yield of 2.70%.
What the numbers say
CleaRank Financial AI's reading of PG's valuation, growth and risks.
PG trades at 24.25 times earnings, versus a Consumer Defensive median of 24.2. That makes its P/E broadly in line with peers, and it sits 0.2% above that median. Measured against sales, the P/S of 4.24 is 92.7% above the sector median of 2.2. Trailing earnings stand at $6.64 a share.
Margins stand at a net margin of 17.9% and an operating margin of 27.06%. It generates a return on equity of 29.61%, above the sector median of 19.7%. Debt-to-equity of 0.70 and a trailing dividend yield of 2.70% ($4.32 a share a year) round out the fundamentals.
PG's October 22, 2026 report came in ahead of forecasts, beating the estimate by 5.82%: EPS was $2.00 against the $1.89 analysts had expected. Even so, the share price dropped 2.76% in the following session.
Across the 6 reports in our data, PG beat the estimate every time, but beats have not guaranteed gains: the stock fell the next day after 4 of them. Analysts' average EPS estimate for this fiscal year is $6.99, which would be growth of 1.4%, and $7.41 for next year (growth of 6.0%).
PG's average daily move is 1.57%, and its beta against the S&P 500 is 0.38. Insiders sold $89.7M of stock over the last 18 months and made no open-market purchases. Sales like these are often planned ahead or made to cover tax on vesting shares, which makes them a weaker signal than buying would be.
PG against the Consumer Defensive sector
How PG compares with the median Consumer Defensive stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (0% difference), suggesting fair market pricing relative to industry standards.
Return vs SPY: Since May 14, 2025, PG has gained 1.2% against a gain of 30.2% for SPY.
Performance against SPY
PG and the S&P 500 (SPY) over the same days.
Revenue and earnings
How much PG sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to June 30, 2026); PG reported again on October 22, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 3.3% in FY2026 to $87.0B, from $84.3B a year earlier.
Profit margin: The net margin was 18.5% in FY2026, down from 19.1% the year before.
Profitable: PG earned $16.1B in FY2026.
Earnings reality check
Did PG beat what analysts expected, and how did the stock react?
Earnings record: PG beat the analyst estimate in 6 of the 6 reports in our data.
Market reaction: The stock fell in the first session after 4 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 22, 2026after close | $1.89 | $2.00 | +5.82% | -2.76% | - |
| Jul 29, 2026after close | $1.41 | $1.43 | +1.42% | -1.46% | +0.48% |
| Jan 22, 2026after close | $1.86 | $1.88 | +1.08% | +0.15% | -0.02% |
| Oct 24, 2025after close | $1.90 | $1.99 | +4.74% | -0.49% | -1.39% |
| Jul 29, 2025after close | $1.42 | $1.48 | +4.23% | -2.38% | -3.90% |
| Apr 24, 2025after close | $1.53 | $1.54 | +0.65% | +0.93% | +0.28% |
As of October 26, 2026, PG has beaten the analyst EPS estimate in 6 of the 6 reports in our data and fell in the first trading session after 4 of those beats; its latest report, on October 22, 2026, came in 5.82% above the estimate and the stock moved -2.76% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
PG AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 61.3, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 61.3 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of PG
The score, the reasoning behind it, and what could move the price next.
PG's trend is pointing up. The price of $159.92 sits 7.61% above its 200-day average of $148.61 and 7.56% above its 50-day average of $148.67. Sitting at 75% of its 52-week range, the stock is 4.38% below its 52-week high of $167.25. Meanwhile the 50-day average is 0.05% above the 200-day average.
On momentum, the 14-day RSI reads 61.3, in the bullish zone, below the overbought line, with the MACD line positive. The recent returns all show a gain, with the price up 7.60% over the past three months, 7.76% over the past six months and 4.87% over the past year.
Analyst upgrade ›
Evercore ISI Group upgraded it to Outperform from In-Line on October 6, 2026.
Source: Analyst action, Evercore ISI Group, October 6, 2026
Analyst downgrade ›
Argus Research downgraded it to Hold from Buy on August 7, 2026.
Source: Analyst action, Argus Research, August 7, 2026
Earnings beat, but the stock fell ›
The October 22, 2026 report beat the EPS estimate by 5.82%, and the share price fell 2.76% in the first session after it.
Source: Earnings report, October 22, 2026
- The two closest levels to watch are the 52-week high of $167.25, which sits above the price, and the 20-day EMA of $155.05, which sits below it.
- The 14-day RSI reads 61.3, in the bullish zone, with the MACD line positive; readings above 70 or below 30 mark stretched momentum.
- After the October 22, 2026 report the share price fell 2.76% in the first session; PG beat estimates in 6 of the 6 reports in our data.
PG trades above its 50-day and 200-day moving averages ($148.67 and $148.61), which is what makes the trend up; losing the 50-day would be the first warning. The nearest level under the price is the 20-day EMA at $155.05.
PG's next overhead level is its 52-week high of $167.25. The RSI reading sits in the bullish band, which backs the current direction without signalling an overstretched move.
Technical indicators
Momentum and trend for PG, from its daily closes.
As of October 26, 2026, with PG at $159.92, its 14-day RSI is 61.3 (showing bullish momentum without being overbought), its 50-day simple moving average is $148.67 and its 200-day is $148.61.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What PG moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, PG's 1-year correlation of daily returns is +0.07 with S&P 500 (SPY), -0.10 with Nasdaq 100 (QQQ), -0.18 with Bitcoin (BTC) and -0.01 with gold (XAU).
PG price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
13 of 25 analysts rate it a buy or strong buy, 12 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $163.00 is 1.9% above the price.More buy ratings than three months ago ›
13 of 25 rate it a buy now, against 14 of 25 three months ago.
PG Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 14, 2026 | Citigroup | Maintains | Buy |
| Oct 6, 2026 | Evercore ISI Group | Upgrade | Outperform |
| Oct 6, 2026 | RBC Capital | Maintains | Outperform |
| Sep 30, 2026 | TD Cowen | Reiterates | Hold |
| Aug 7, 2026 | Argus Research | Downgrade | Hold |
| Jul 30, 2026 | HSBC | Downgrade | Hold |
As of October 26, 2026, 25 Wall Street analysts cover PG: 13 rate it a buy or strong buy, 12 a hold and 0 a sell or strong sell. Their 12-month price targets range from $143.00 to $186.00. The median PG price target is $163.00, 1.9% above the price of $159.92.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
PG trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
PG trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from PG's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much PG tends to move, against the market and on its own.
PG price history and drawdowns
PG's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.57% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 22.6%, from September 2017 to May 2018, regained by November 2018.Most 1-year holds ended higher ›
70% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $24,181, against $42,015 in the S&P 500 (SPY).
PG Drawdowns & Recovery
As of October 26, 2026, PG's worst peak-to-trough fall over the last 10 years with dividends reinvested was -22.6% (September 2017 to May 2018); it regained that peak by November 2018, 6 months after the low, and 70% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into PG in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: PG trailed the S&P 500 over this period: $24,181 against $42,015.
A $10,000 investment in PG in October 2016 would be worth about $24,181 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to PG, and which have not.
Strongest month, November: an average of +2.68%, up in 7 of 10 years.
Weakest month, March: an average of -0.72%, up in 6 of 10 years.
This month, October: has averaged +1.08%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, PG's strongest calendar month has been November (average +2.68%, up in 7 of 10 years) and its weakest March (average -0.72%, up in 6 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
PG stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in PG, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in PG today could grow to about $12,772 by 2030 in the base case, with a 90th-percentile outcome near $20,985 and a 10th-percentile outcome around $7,773. The simulation models price only; at today's 2.70% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
PG Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $204 for PG by 2030 in the base case, from $160 today (1.3x over 4 years). The 10th-percentile path ends near $124. These are outcomes of a Monte Carlo simulation run on PG's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $133 | $170 | $218 | |
| 2028 | $127 | $181 | $257 | |
| 2029 | $125 | $192 | $295 | |
| 2030 | $124 | $204 | $336 |
Method: a lognormal simulation of PG's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
PG insider trading
What the people running the company have bought and sold.
PG insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought PG shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, PG insiders reported 48 open-market sales worth $89.7M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Bertrand Marc Allen
Director
|
Grant | 1.4K | - |
| Oct 13, 2026 | Craig Arnold
Director
|
Grant | 1.4K | - |
| Oct 13, 2026 | M Brett Biggs
Director
|
Grant | 1.4K | - |
| Oct 13, 2026 | Sheila Bonini
Director
|
Grant | 1.4K | - |
| Oct 13, 2026 | Amy L Chang
Director
|
Grant | 1.4K | - |
| Oct 13, 2026 | Joseph Jimenez Jr
Director
|
Grant | 1.4K | - |
| Oct 13, 2026 | Christopher J Kempczinski
Director
|
Grant | 1.4K | - |
| Oct 13, 2026 | Christine M. Mccarthy
Director
|
Grant | 1.4K | - |
| Oct 13, 2026 | Ashley Mcevoy
Director
|
Grant | 1.4K | - |
| Oct 13, 2026 | Robert Jones Portman
Director
|
Grant | 1.4K | - |
| Oct 13, 2026 | Rajesh Subramaniam
Director
|
Grant | 1.4K | - |
| Oct 5, 2026 | Andre Schulten
Chief Financial Officer
|
Sell | 3.9K | $568.9K |
| Oct 5, 2026 | Susan Street Whaley
Officer
|
Sell | 2.4K | $344.3K |
| Oct 5, 2026 | Paul Gama
Officer
|
Sell | 2.2K | $323.4K |
| Oct 1, 2026 | Moses Victor Javier Aguilar
Officer
|
Grant | 5.7K | - |
| Oct 1, 2026 | Paul Gama
Officer
|
Grant | 12.5K | - |
| Oct 1, 2026 | Shailesh Jejurikar
Chief Executive Officer
|
Grant | 16.1K | - |
| Oct 1, 2026 | Andre Schulten
Chief Financial Officer
|
Grant | 6.6K | - |
| Oct 1, 2026 | Susan Street Whaley
Officer
|
Grant | 6.1K | - |
| Sep 8, 2026 | Craig Arnold
Director
|
Grant | 207 | - |
| Sep 8, 2026 | Joseph Jimenez Jr
Director
|
Grant | 327 | - |
| Sep 8, 2026 | Christopher J Kempczinski
Director
|
Grant | 250 | - |
| Sep 8, 2026 | Christine M. Mccarthy
Director
|
Grant | 258 | - |
| Sep 8, 2026 | Ashley Mcevoy
Director
|
Grant | 207 | - |
| Sep 8, 2026 | Robert Jones Portman
Director
|
Grant | 52 | - |
| Aug 24, 2026 | Matthew W. Janzaruk
Officer
|
Sell | 359 | $52.1K |
| Aug 21, 2026 | Sundar G. Raman
Officer
|
Sell | 3.4K | $491.3K |
| Aug 20, 2026 | Shailesh Jejurikar
Chief Executive Officer
|
Sell | 6.2K | $888.0K |
| Aug 20, 2026 | Andre Schulten
Chief Financial Officer
|
Sell | 5.4K | $776.8K |
| Aug 20, 2026 | Paul Gama
Officer
|
Sell | 3.4K | $488.3K |
| Aug 20, 2026 | Moses Victor Javier Aguilar
Officer
|
Sell | 3.1K | $439.0K |
| Aug 20, 2026 | Balaji Purushothaman
Officer
|
Sell | 2.0K | $290.3K |
| Aug 20, 2026 | El Hak Hesham Abd
Officer
|
Sell | 1.9K | $278.4K |
| Aug 20, 2026 | Freddy P Bharucha
Officer
|
Sell | 246 | $35.4K |
| Aug 20, 2026 | Matthew W. Janzaruk
Officer
|
Sell | 156 | $22.4K |
| Aug 19, 2026 | Moses Victor Javier Aguilar
Officer
|
Sell | 3.1K | $439.0K |
| Aug 19, 2026 | El Hak Hesham Abd
Officer
|
Grant | 5.1K | - |
| Aug 19, 2026 | Moses Victor Javier Aguilar
Officer
|
Grant | 6.8K | - |
| Aug 19, 2026 | Freddy P Bharucha
Officer
|
Grant | 837 | - |
| Aug 19, 2026 | Paul Gama
Officer
|
Grant | 7.7K | - |
| Aug 19, 2026 | Matthew W. Janzaruk
Officer
|
Grant | 515 | - |
| Aug 19, 2026 | Shailesh Jejurikar
Chief Executive Officer
|
Grant | 16.2K | - |
| Aug 19, 2026 | Marc S Pritchard
Officer
|
Grant | 7.9K | - |
| Aug 19, 2026 | Balaji Purushothaman
Officer
|
Grant | 4.8K | - |
| Aug 19, 2026 | Sundar G. Raman
Officer
|
Grant | 9.3K | - |
| Aug 19, 2026 | Andre Schulten
Chief Financial Officer
|
Grant | 14.5K | - |
| Aug 19, 2026 | Susan Street Whaley
Officer
|
Grant | 7.4K | - |
| Aug 18, 2026 | Susan Street Whaley
Officer
|
Sell | 8.6K | $1.2M |
| Aug 6, 2026 | Matthew W. Janzaruk
Officer
|
Grant | 278 | - |
| Jun 9, 2026 | Craig Arnold
Director
|
Grant | 202 | - |
| Jun 9, 2026 | Joseph Jimenez Jr
Director
|
Grant | 320 | - |
| Jun 9, 2026 | Christopher J Kempczinski
Director
|
Grant | 258 | - |
| Jun 9, 2026 | Christine M. Mccarthy
Director
|
Grant | 253 | - |
| Jun 9, 2026 | Ashley Mcevoy
Director
|
Grant | 202 | - |
| Jun 9, 2026 | Robert Jones Portman
Director
|
Grant | 51 | - |
| Mar 10, 2026 | Craig Arnold
Director
|
Grant | 161 | - |
| Mar 10, 2026 | Joseph Jimenez Jr
Director
|
Grant | 273 | - |
| Mar 10, 2026 | Christopher J Kempczinski
Director
|
Grant | 201 | - |
| Mar 10, 2026 | Christine M. Mccarthy
Director
|
Grant | 209 | - |
| Mar 10, 2026 | Ashley Mcevoy
Director
|
Grant | 161 | - |
| Mar 10, 2026 | Robert Jones Portman
Director
|
Grant | 193 | - |
| Mar 10, 2026 | Robert Jones Portman
Director
|
Grant | 49 | - |
| Feb 27, 2026 | Ma. Fatima Francisco
Officer
|
Sell | 5.5K | $917.2K |
| Feb 19, 2026 | Susan Street Whaley
Officer
|
Sell | 1.8K | $288.5K |
| Feb 13, 2026 | Moses Victor Javier Aguilar
Officer
|
Sell | 15.2K | $2.5M |
| Feb 13, 2026 | Moses Victor Javier Aguilar
Officer
|
Option | 15.2K | $1.4M |
| Feb 12, 2026 | Jon R Moeller
Officer and Director
|
Sell | 173.3K | $28.1M |
| Feb 12, 2026 | Gary A Coombe
Officer
|
Sell | 36.1K | $5.9M |
| Feb 12, 2026 | Gary A Coombe
Officer
|
Option | 36.1K | $2.8M |
| Feb 12, 2026 | Jon R Moeller
Officer and Director
|
Option | 173.3K | $19.6M |
| Feb 11, 2026 | Balaji Purushothaman
Officer
|
Sell | 12.8K | $2.1M |
| Feb 11, 2026 | Balaji Purushothaman
Officer
|
Option | 12.8K | $1.2M |
| Feb 4, 2026 | Ma. Fatima Francisco
Officer
|
Sell | 8.0K | $1.3M |
| Jan 23, 2026 | Marc S Pritchard
Officer
|
Sell | 95.9K | $14.5M |
| Jan 23, 2026 | Marc S Pritchard
Officer
|
Option | 95.9K | $7.7M |
| Dec 9, 2025 | Craig Arnold
Director
|
Grant | 215 | - |
| Dec 9, 2025 | Joseph Jimenez Jr
Director
|
Grant | 341 | - |
| Dec 9, 2025 | Christopher J Kempczinski
Director
|
Grant | 260 | - |
| Dec 9, 2025 | Christine M. Mccarthy
Director
|
Grant | 269 | - |
| Dec 9, 2025 | Ashley Mcevoy
Director
|
Grant | 215 | - |
| Dec 9, 2025 | Robert Jones Portman
Director
|
Grant | 54 | - |
| Dec 3, 2025 | Moses Victor Javier Aguilar
Officer
|
Option | 55 | $8.0K |
| Dec 3, 2025 | Freddy P Bharucha
Officer
|
Option | 45 | $6.5K |
| Dec 3, 2025 | Jennifer L Davis
Officer
|
Option | 60 | $8.7K |
| Dec 3, 2025 | Ma. Fatima Francisco
Officer
|
Option | 73 | $10.6K |
| Dec 3, 2025 | Shailesh Jejurikar
Chief Operating Officer
|
Option | 51 | $7.4K |
| Dec 3, 2025 | Jon R Moeller
Chief Executive Officer
|
Option | 159 | $23.0K |
| Dec 3, 2025 | Marc S Pritchard
Officer
|
Option | 94 | $13.7K |
| Dec 3, 2025 | Balaji Purushothaman
Officer
|
Option | 38 | $5.5K |
| Dec 3, 2025 | Sundar G. Raman
Officer
|
Option | 59 | $8.6K |
| Dec 3, 2025 | Andre Schulten
Chief Financial Officer
|
Option | 88 | $12.8K |
| Dec 3, 2025 | Susan Street Whaley
Officer
|
Option | 54 | $7.9K |
| Nov 10, 2025 | Andre Schulten
Chief Financial Officer
|
Sell | 1 | $190 |
| Nov 5, 2025 | Ma. Fatima Francisco
Officer
|
Grant | 12.7K | - |
| Oct 30, 2025 | Matthew W. Janzaruk
Officer
|
Sell | 725 | $108.4K |
| Oct 14, 2025 | Bertrand Marc Allen
Director
|
Grant | 1.5K | - |
| Oct 14, 2025 | Craig Arnold
Director
|
Grant | 1.5K | - |
| Oct 14, 2025 | M Brett Biggs
Director
|
Grant | 1.5K | - |
| Oct 14, 2025 | Sheila Bonini
Director
|
Grant | 1.5K | - |
| Oct 14, 2025 | Amy L Chang
Director
|
Grant | 1.5K | - |
| Oct 14, 2025 | Joseph Jimenez Jr
Director
|
Grant | 1.5K | - |
| Oct 14, 2025 | Christopher J Kempczinski
Director
|
Grant | 1.5K | - |
| Oct 14, 2025 | Debra L Lee
Director
|
Grant | 1.5K | - |
| Oct 14, 2025 | Terry J Lundgren
Director
|
Grant | 31 | - |
| Oct 14, 2025 | Christine M. Mccarthy
Director
|
Grant | 1.5K | - |
| Oct 14, 2025 | Ashley Mcevoy
Director
|
Grant | 1.5K | - |
| Oct 14, 2025 | Robert Jones Portman
Director
|
Grant | 1.5K | - |
| Oct 14, 2025 | Rajesh Subramaniam
Director
|
Grant | 1.5K | - |
| Oct 14, 2025 | Patricia A Woertz
Director
|
Grant | 31 | - |
| Oct 2, 2025 | Jon R Moeller
Chief Executive Officer
|
Sell | 11.7K | $1.8M |
| Oct 2, 2025 | Andre Schulten
Chief Financial Officer
|
Sell | 4.3K | $647.3K |
| Oct 2, 2025 | Shailesh Jejurikar
Chief Operating Officer
|
Sell | 4.0K | $606.8K |
| Oct 2, 2025 | Gary A Coombe
Officer
|
Sell | 3.5K | $538.1K |
| Oct 2, 2025 | Jennifer L Davis
Officer
|
Sell | 3.2K | $491.3K |
| Oct 2, 2025 | Susan Street Whaley
Officer
|
Sell | 2.4K | $366.6K |
| Oct 2, 2025 | R Alexandra Keith
Officer
|
Sell | 2.3K | $343.1K |
| Oct 2, 2025 | Balaji Purushothaman
Officer
|
Sell | 490 | $74.6K |
| Oct 1, 2025 | Moses Victor Javier Aguilar
Officer
|
Grant | 4.9K | - |
| Oct 1, 2025 | Gary A Coombe
Officer
|
Grant | 3.4K | - |
| Oct 1, 2025 | Shailesh Jejurikar
Chief Operating Officer
|
Grant | 22.8K | - |
Source: TwelveData, from SEC Form 4 filings
PG stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.